Journals / Erciyes Tıp Dergisi / 2007 / Cilt: 29 - Sayı: 1

The effects of conventional gonadotrophin therapy on lymphocyte subgroups and its association with IL-2R expression in patients with idiopathichypogonadotrophic hypogonadism

İdiyopatik hipogonadotropik hipogonadizmli hastalarda konvansiyonel gonadotropin tedavisinin lenfosit alt gurupları üzerine etkilerive IL-2 reseptör (IL-2R) ekspresyonu ile ilişkisi

Pages
1–6
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Quantitative Real-Time RT-PCR was used to examine the express ion of IL-2R (target gene) and beta-aktin (reference gene) in peripheral mononuclear blood cells (PMBCs) derived from patients and controls.Results: In the patient group, before treatment total lymphocyte count was significantly high and the mean CD4 percentage was significantly low when compared to the results of healthy controls (P

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: Although the presence of the interaction between sex steroids and the immune system is known, the mechanism of this interaction, which is very important in understanding the pathogenesis of the autoimmune disorders, is still unclear.
📊
Key Findings & Data:In-vivo interaction of testosterone and IL-2R expression at lymphocyte level has not yet been investigated.
💡
Conclusion & Impact:Quantitative Real-Time RT-PCR was used to examine the express ion of IL-2R (target gene) and beta-aktin (reference gene) in peripheral mononuclear blood cells (PMBCs) derived from patients and controls.Results: In the patient group, before treatment total lymphocyte count was significantly high and the mean CD4 percentage was significantly low when compared to the results of healthy controls (P
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Purpose: Although the presence of the interaction between sex steroids and the immune system is known, the mechanism of this interaction, which is very important in understanding the pathogenesis of the autoimmune disorders, is still unclear. In-vivo interaction of testosterone and IL-2R expression at lymphocyte level has not yet been investigated. Therefore, in the present study, we report the preliminary results of our ongoing study regarding the effects of conventional gonadotrophin therapy on lymphocyte subgroups and its relation with IL-2R expression in patients with idiopathic hypogonadotrophic hypogonadism (IHH). Materials and Method: Peripheral venous blood samples were obtained from 10 patients with IHH (Mean age 25.6 ± 7.1 years) and 10 age- and sex-matchedhealthy volunteers (Mean age 27.1 ± 3.9 years). Patients were treated for 12 months (3 days a week) with hCG and hMG. Lymphocyte subtype levels including CD3, CD4, CD8, CD16 and CD19 were analyzed by flow cytometry. Quantitative Real-Time RT-PCR was used to examine the express ion of IL-2R (target gene) and beta-aktin (reference gene) in peripheral mononuclear blood cells (PMBCs) derived from patients and controls.Results: In the patient group, before treatment total lymphocyte count was significantly high and the mean CD4 percentage was significantly low when compared to the results of healthy controls (P

Özet

Amaç: Seks steroidleri ve immün sistem ilişkisinin varlığı insanda bilinmekle birlikte, otoimmün hastalıkların patogenezini anlamak için gerekli olan bu ilişkinin mekanizması halen açık değildir. Erkeklerdeki major seks steroidlerinden olan testosteron ile IL-2R ekspresyonunun lenfosit düzeyindeki fonksiyonel ilişkisi insanda in-vivo ortamda henüz incelenmemiştir. Bu nedenlerden dolay idyopatik hipopogonadotropik hipogonadizmli (İHH) hastalarda planladığımız, konvansiyonel gonadotropin tedavisinin lenfosit alt gurupları ve periferal mononükleer hücrelerdeki (PMBC) IL-2R ekspresyonu üzerine etkileriyle ilgili araştırmanın ön çalışma sonuçlarını sunacağız. Gereç ve Yöntem: İHH tanısı alan 10 erkek hasta (ortalama yaş 25,6 ± 7,1) ve yaş/cinsiyet eşleştirilmiş 10 sağlıklı kontrol (ortalama yaş 27,1 ± 3,9) çalışmaya alınmıştır. Hastalar 12 ay boyunca haftada 3 gün; hCG ve human postmenopozal gonadotropin (hMG) ile tedavi edilmiştir. Lenfosit alt guruplarından CD3, CD4, CD8, CD16 ve CD19 yüzdeleri flow sitometri ile ölçülmüştür. Quantitative real-time PCR ile kontrollerin PMBC’lerinden elde edilen cDNA’larda IL-2R (hedef gen) ve beta-aktin (referans gen) ekspresyonu analiz edilmiştir. Bulgular: Hasta gurubunda tedavi öncesi total lenfosit sayısı kontrollere göre anlamlı olarak yüksek ve ortalama CD4 yüzdesi ise anlamlı olarak düşüktü (P

🔖

Cite This Article

PATIROĞLU, T., DÜNDAR, M., AKALIN, H., TANRIVERDİ, F., DEMİRKOPARAN, Ü., ÖZKUL, Y., BAYRAM, F. (2022). The effects of conventional gonadotrophin therapy on lymphocyte subgroups and its association with IL-2R expression in patients with idiopathichypogonadotrophic hypogonadism. Erciyes Tıp Dergisi, Cilt: 29 - Sayı: 1, 1–6. https://ajindex.com/articles/502747

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Conn PM, Crowley WF Jr. Gonadotropin-releasing hormone and its analogues. N Engl J Med 1991; 324:93-103
  2. Kakar SS, Musgrove LC, Devor DC, Sellers JC, Neill JD. Cloning, sequencing, and expression of human gonadotropin releasing hormone (GnRH) receptor. Biochem Biophys Res Commun 1992;189:289-295
  3. Azad N, La Paglia N, Jurgens KA, et al. Immunoactivation enhances the concentration of luteinizing hormone-releasing hormone peptide and its gene expression in human peripheral T-lymphocytes. Endocrinology 1993;133:215-223
  4. Azad N, LaPaglia N, Kirsteins L, et al. Jurkat cell proliferative activity is increased by luteinizing hormone-releasing hormone. J Endocrinol 1997; 153:241-249
  5. Tanriverdi F, Silveira LF, MacColl GS, Bouloux PM. The hypothalamic-pituitary-gonadal axis: immune function and autoimmunity. J Endocrinol 2003;176:293-304
  6. White RB, Eisen JA, Kasten TL, Fernald RD. Second gene for gonadotropin-releasing hormone in humans. Proc Natl Acad Sci U S A 1998;95:305-309
  7. Chen A, Ganor Y, Rahimipour S, Ben-Aroya N, Koch Y, Levite M. The neuropeptides GnRH-II and GnRH-I are produced by human T cells and trigger laminin receptor gene expression, adhesion, chemotaxis and homing to specific organs. Nat Med 2002;8:1421-1426
  8. Tanriverdi F, Gonzalez-Martinez D, Silveira LF, et al. Expression of Gonadotropin-Releasing Hormone Type-I (GnRH- I) and Type-II (GnRH-II) in Human Peripheral Blood Mononuclear Cells (PMBCs) and Regulation of B- Lymphoblastoid Cell Proliferation by GnRH-I and GnRH-II. Exper Clin Endocrinol & Diabetes 2004;112:587-594
  9. Batticane N, Morale MC, Gallo F, Farinella Z, Marchetti B. Luteinizing hormone-releasing hormone signaling at the lymphocyte involves stimulation of interleukin-2 receptor expression. Endocrinology 1991;129:277-286
  10. Chen HF, Jeung EB, Stephenson M, Leung PC. Human peripheral blood mononuclear cells express gonadotropin- releasing hormone (GnRH), GnRH receptor, and interleukin- 2 receptor gamma-chain messenger ribonucleic acids that are regulated by GnRH in vitro. J Clin Endocrinol Metab 1999;84:743-750
  11. Barak V, Mordel N, Zajicek G, Kalichman I, Treves AJ, Laufer N. The correlation between interleukin 2 and soluble interleukin 2 receptors to oestradiol, progesterone and testosterone levels in periovulatory follicles of in-vitro fertilization patients. Hum Reprod 1992;7:926-929
  12. Messingham KA, Messingham KA, Shirazi M, et al. Testosterone receptor blockade restores cellular immunity in male